About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

ProPhase Arbitration Ruling Handed Down

November 16, 2016

Click here to read more

Post navigation

Phosphagenics Extends Due Diligence Period for Opioid Patches in Japan

Reformulation of Phosphagenics Transdermal TPM/Oxymorphone Patch Complete

Related Posts

Phosphagenics Signs Development Agreement with tesa Labtec for TPM/Oxymorphone Patch

October 22, 2015

Phosphagenics Newsletter July 2015

July 9, 2015

Appointment of Non-Executive Director

May 19, 2016

Recent Posts

AusBiz | Dr Paul Gavin
July 28, 2021
Quarterly Activities Report and 4C
July 27, 2021
Peak TV Interview
May 31, 2021

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.